The story of Viagra presents a challenging picture for investors. While the initial launch generated significant gains, the expiration of its patent opened the floodgates to cheaper competitors, dramatically eroding https://bookmarkfriend.com/story21677286/viagra-and-big-pharma-a-risky-investment